Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 4, 2009, Pages 388-392

  Jayachandra Babu, R ^a   Ravis, W R ^a   Duran, S H ^b   Schumacher, J ^b   Cox, E ^b   Stahl, R ^b   Jones, K ^b   Jean Lin, Y J ^a   Phillip Lee, Y H ^a   Parsons, D L ^a   Portman, E M ^c   Brown, S C R ^c  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

^c PharmaDerm Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOSUBSTITUTED ALKYL AMIDE; PENETRATION ENHANCING AGENT; PHENYLBUTAZONE; PHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DEER; DRUG FORMULATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; LIPOSOMAL DELIVERY; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION;

ADMINISTRATION, CUTANEOUS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEER; GELS; LIPOSOMES; PHENYLBUTAZONE; SKIN ABSORPTION;

ANIMALIA; CERVIDAE;

EID: 67651252505     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01060.x     Document Type: Article

References (14)

1. Cheng, Z., Nolan, A.M. McKeller, Q.A. (1998) Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation, 22, 353 366.
2. Eberhardson, B., Olsson, G., Appelgren, L.E. Jacobsson, S.O. (1979) Pharmacokinetic studies of phenylbutazone in cattle. Journal of Veterinary Pharmacology and Therapeutics, 2, 31 37.
3. Elbaum, D., Pandolfelli, E.R. Herskovits, T.T. (1974) Denaturation of human and Glycera dibranchiata hemoglobins by the urea and amide classes of denaturants. Biochemistry, 13, 1278 1284.
4. Guy, R.H. (1996) Current status and future prospects of transdermal drug delivery. Pharmaceutical Research, 13, 1765 1769.
5. Han, S.K., Jun, Y.H., Rho, Y.J., Hong, S.C. Kim, Y.M. (1991) Percutaneous absorption-enhancing activity of urea derivatives. Archives of Pharmacal Research, 14, 12 18.
6. Lees, P., Ayliffe, T., Maitho, T.E. Taylor, J.B.O. (1988) Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration. Research in Veterinary Science, 44, 57 67.
7. Magnusson, B.M., Walters, K.A. Roberts, M.S. (2001) Veterinary drug delivery: potential for skin penetration enhancement. Advanced Drug Delivery Reviews, 50, 205 227.
8. Mills, P.C. Cross, S.E. (2006) Transdermal drug delivery: basic principles for the veterinarian. Veterinary Journal, 172, 218 233.
9. Navarre, C.B., Ravis, W.R., Nagilla, R., Simpkins, A., Duran, S.H. Pugh, D.G. (2001) Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses. Journal of Veterinary Pharmacology and Therapeutics, 24, 227 231. (Pubitemid 32623375)
10. Roberts, M.S., Cross, S.E. Pellet, M.A. (2002) Skin transport. In Dermatological and Transdermal Formulations. Ed. Walters, K.A., pp. 89 196. Marcel Dekker, New York.
11. Rubinstein, A. (1999). Methods of Using a Butylurea gel Composition for the Treatment and Prevention of Infections, 16 pp. Albert Einstein College of Medicine of Yeshiva University, USA, Application: WO
12. Tanford, C. (1968) Protein denaturation. Advances in Protein Chemistry, 23, 121 282.
13. Warren, J.R. Gordon, J.A. (1976) The nature of alkylurea and urea denaturation of alpha-chymotrypsinogen. Biochimca et Biophysica Acta, 420, 397 405.
14. Zhang, J. (2007). Dermatological Composition Containing Alkyl Ureas, 8 pp. US-PTO, Chadwick, GraysLake, IL, USA. Application: US.